These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 39119901

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Dose Reduction of Caspofungin in Intensive Care Unit Patients with Child Pugh B Will Result in Suboptimal Exposure.
    Martial LC, Brüggemann RJ, Schouten JA, van Leeuwen HJ, van Zanten AR, de Lange DW, Muilwijk EW, Verweij PE, Burger DM, Aarnoutse RE, Pickkers P, Dorlo TP.
    Clin Pharmacokinet; 2016 Jun; 55(6):723-33. PubMed ID: 26649870
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Assessment of echinocandin regimens by pharmacokinetic/pharmacodynamic analysis against Candida spp. in paediatric patients.
    Xu G, Zhu L, Liao S, Ge T, Yang J.
    Int J Antimicrob Agents; 2015 Dec; 46(6):631-41. PubMed ID: 26602452
    [Abstract] [Full Text] [Related]

  • 6. Overcoming the Resistance Hurdle: Pharmacokinetic-Pharmacodynamic Target Attainment Analyses for Rezafungin (CD101) against Candida albicans and Candida glabrata.
    Bader JC, Lakota EA, Flanagan S, Ong V, Sandison T, Rubino CM, Bhavnani SM, Ambrose PG.
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555634
    [Abstract] [Full Text] [Related]

  • 7. Population Pharmacokinetics of Caspofungin and Dosing Optimization in Children With Allogeneic Hematopoietic Stem Cell Transplantation.
    Niu CH, Xu H, Gao LL, Nie YM, Xing LP, Yu LP, Wu SL, Wang Y.
    Front Pharmacol; 2020 Jun; 11():184. PubMed ID: 32194415
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic/pharmacodynamic adequacy of echinocandins against Candida spp. in intensive care unit patients and general patient populations.
    Yang Q, Wang T, Xie J, Wang Y, Zheng X, Chen L, Li Y, Meng T, Dong Y.
    Int J Antimicrob Agents; 2016 May; 47(5):397-402. PubMed ID: 27068676
    [Abstract] [Full Text] [Related]

  • 9. Assessment of micafungin dosage regimens against Candida spp. in pediatric patients undergoing hematopoietic stem cell transplantation: a pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulation.
    Wei XC, Zhao MF, Xiao X.
    J Chemother; 2023 Dec; 35(8):721-729. PubMed ID: 37190751
    [Abstract] [Full Text] [Related]

  • 10. In vivo comparison of the pharmacodynamic targets for echinocandin drugs against Candida species.
    Andes D, Diekema DJ, Pfaller MA, Bohrmuller J, Marchillo K, Lepak A.
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2497-506. PubMed ID: 20385855
    [Abstract] [Full Text] [Related]

  • 11. Population pharmacokinetics/pharmacodynamics of micafungin against Candida species in obese, critically ill, and morbidly obese critically ill patients.
    Maseda E, Grau S, Luque S, Castillo-Mafla MP, Suárez-de-la-Rica A, Montero-Feijoo A, Salgado P, Gimenez MJ, García-Bernedo CA, Gilsanz F, Roberts JA.
    Crit Care; 2018 Apr 15; 22(1):94. PubMed ID: 29655372
    [Abstract] [Full Text] [Related]

  • 12. Population pharmacokinetics of fluconazole in liver transplantation: implications for target attainment for infections with Candida albicans and non-albicans spp.
    Cojutti PG, Lugano M, Righi E, Della Rocca G, Bassetti M, Hope W, Pea F.
    Eur J Clin Pharmacol; 2018 Nov 15; 74(11):1449-1459. PubMed ID: 30032414
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic/pharmacodynamic analysis of voriconazole against Candida spp. and Aspergillus spp. in children, adolescents and adults by Monte Carlo simulation.
    Xu G, Zhu L, Ge T, Liao S, Li N, Qi F.
    Int J Antimicrob Agents; 2016 Jun 15; 47(6):439-45. PubMed ID: 27179818
    [Abstract] [Full Text] [Related]

  • 14. Micafungin pharmacokinetic/pharmacodynamic adequacy for the treatment of invasive candidiasis in critically ill patients on continuous venovenous haemofiltration.
    Maseda E, Grau S, Villagran MJ, Hernandez-Gancedo C, Lopez-Tofiño A, Roberts JA, Aguilar L, Luque S, Sevillano D, Gimenez MJ, Gilsanz F.
    J Antimicrob Chemother; 2014 Jun 15; 69(6):1624-32. PubMed ID: 24505092
    [Abstract] [Full Text] [Related]

  • 15. Assessment of micafungin regimens by pharmacokinetic-pharmacodynamic analysis: a dosing strategy for Aspergillus infections.
    Ikawa K, Nomura K, Morikawa N, Ikeda K, Taniwaki M.
    J Antimicrob Chemother; 2009 Oct 15; 64(4):840-4. PubMed ID: 19700475
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetic/Pharmacodynamic Target Attainment of Different Antifungal Agents in De-escalation Treatment in Critically Ill Patients: a Step toward Dose Optimization Using Monte Carlo Simulation.
    Xie J, Yang Q, Han X, Dong Y, Zhang T, Li Y, Ji M, Liu C, Cai Y, Wang Y.
    Antimicrob Agents Chemother; 2022 Jun 21; 66(6):e0009922. PubMed ID: 35604209
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic study of anidulafungin in ICU patients with intra-abdominal candidiasis.
    Dupont H, Massias L, Jung B, Ammenouche N, Montravers P.
    J Antimicrob Chemother; 2017 May 01; 72(5):1429-1432. PubMed ID: 28088767
    [Abstract] [Full Text] [Related]

  • 18. Pharmacodynamics of echinocandins against Candida glabrata: requirement for dosage escalation to achieve maximal antifungal activity in neutropenic hosts.
    Howard SJ, Livermore J, Sharp A, Goodwin J, Gregson L, Alastruey-Izquierdo A, Perlin DS, Warn PA, Hope WW.
    Antimicrob Agents Chemother; 2011 Oct 01; 55(10):4880-7. PubMed ID: 21807969
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetic/Pharmacodynamic Analysis of Voriconazole Against Candida spp. and Aspergillus spp. in Allogeneic Stem Cell Transplant Recipients.
    Perez-Pitarch A, Guglieri-Lopez B, Ferriols-Lisart R, Pérez A, Ezquer-Garín C, Hernández-Boluda JC, Piñana JL, Navarro D, Solano C, Alós-Almiñana M.
    Ther Drug Monit; 2019 Dec 01; 41(6):740-747. PubMed ID: 31136417
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the probability of target attainment of anidulafungin against Candida spp. in patients with acute leukaemia.
    Doan TN, Kong DC, Patel K, Walker P, Spencer A, Kirkpatrick CM.
    Int J Antimicrob Agents; 2014 Nov 01; 44(5):450-7. PubMed ID: 25261159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.